Effect of beta-adrenoceptor blockade on dipyridamole-induced myocardial asynergies in coronary artery disease.
Twenty-one patients with angiographic evidence of significant coronary artery disease, and positive dipyridamole echocardiographic test results at basal condition and after 7 days of placebo treatment were prospectively studied to see whether beta blockade modifies the effects of dipyridamole echocardiographic testing on regional myocardial contractility. Patients were randomized to propranolol (120 mg/day) or placebo treatment in 3 divided doses for 7 days, after which each patient crossed over to the alternate regimen. Dipyridamole-echocardiographic testing was repeated at the end of each treatment. Propranolol abolished new mechanical signs of transient dipyridamole-induced ischemia (new wall motion abnormalities or an increase in degree of basal asynergies, or both) in 13 of 21 patients. The remaining 8 patients had positive results on dipyridamole echocardiographic testing after the propranolol treatment period. At basal conditions both heart rate and rate-pressure product were significantly reduced with propranolol; there was also a significant decrease in these parameters at peak dipyridamole infusion. At peak dipyridamole infusion heart rate and rate-pressure product were significantly lower in patients with negative than in those with positive echocardiographic test results after propranolol. Our data show that administration of beta blockade significantly reduces the development of transient dipyridamole-induced myocardial asynergies, the earliest markers of acute myocardial ischemia, detected with 2-dimensional echocardiography.
Cattedra di Geriatria, II Facoltà di Medicina e Chirurgia di Napoli, Naples, Italy.
N
N
Ferrara
G
G
Longobardi
A
A
Nicolino
D
D
Acanfora
L
L
Odierna
G
G
Furgi
M
M
Rossi
D
D
Leosco
F
F
Rengo
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D017023:Coronary Angiography; D003327:Coronary Disease / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000503:physiopathology; D004176:Dipyridamole; D004452:Echocardiography / Q000379:methods*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects*; D011292:Premedication; D011433:Propranolol / Q000494:pharmacology*; D011446:Prospective Studies; D015203:Reproducibility of Results
D000319:Adrenergic beta-Antagonists; D004176:Dipyridamole; D011433:Propranolol